| Title | Transplantation and Cellular Therapy |
| Abbreviation | Transplant. Cell. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cell Biology (Q1); Hematology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Transplantation (Q1) |
| h-index | 147 |
| Overall Rank/Ranking | 1206 |
| SCImago Journal Rank (SJR) | 2.195 |
| Impact Score | 4.05 |
| Publisher | Elsevier B.V. |
| Country | Netherlands |
| ISSN | 26666367, 26666375 |
| Best Quartile | Q1 |
| Coverage History | 2021-2025 |
Transplantation and Cellular Therapy is a journal covering the technologies/fields/categories related to Cell Biology (Q1); Hematology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Transplantation (Q1). It is published by Elsevier B.V.. The overall rank of Transplantation and Cellular Therapy is 1206. According to SCImago Journal Rank (SJR), this journal is ranked 2.195. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 147. The best quartile for this journal is Q1.
The ISSN of Transplantation and Cellular Therapy journal is 26666367, 26666375. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Transplantation and Cellular Therapy is cited by a total of 4039 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Transplantation and Cellular Therapy is 4.05, which is computed in 2025 as per its definition. Transplantation and Cellular Therapy IF is increased by a factor of 0.66 and approximate percentage change is 19.47% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Transplantation and Cellular Therapy is 4.05. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.05 |
| 2023 | 3.39 |
| 2022 | 3.27 |
| 2021 | 4.27 |
| 2020 | 4.12 |
| 2019 | 3.47 |
| 2018 | 3.34 |
| 2017 | 4.10 |
| 2016 | 4.16 |
| 2015 | 3.65 |
| 2014 | 3.35 |
Transplantation and Cellular Therapy has an h-index of 147. It means 147 articles of this journal have more than 147 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Transplantation and Cellular Therapy is 26666367, 26666375. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Transplantation and Cellular Therapy is 1206. According to SCImago Journal Rank (SJR), this journal is ranked 2.195. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2.195 |
| 2023 | 1.602 |
| 2022 | 1.814 |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1206 |
| 2023 | 2010 |
| 2022 | 1550 |
| 2021 | 28221 |
| 2020 | 34900 |
| 2019 | 32646 |
| 2018 | 34106 |
| 2017 | 34879 |
| 2016 | 34285 |
| 2015 | 33713 |
| 2014 | 32973 |
Transplantation and Cellular Therapy is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2021-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Transplantation and Cellular Therapy is Transplant. Cell. Ther.. This abbreviation ('Transplant. Cell. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cell Biology (Q1); Hematology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Transplantation (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Transplantation and Cellular Therapy latest impact IF is 4.05. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.27 (2021) and 3.27 (2022), respectively, in the last 11 years. Moreover, its average IS is 3.74 in the previous 11 years.
The Transplantation and Cellular Therapy has an SJR (SCImago Journal Rank) of 2.195, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 2.195 in 2024 and the lowest being in 2021. Furthermore, the average SJR of the Transplantation and Cellular Therapy over the previous 11-year period stands at 3.74.
The latest h-index of the Transplantation and Cellular Therapy is 147.
The Transplantation and Cellular Therapy is published by the Elsevier B.V., with its country of publication being the Netherlands.
The Transplantation and Cellular Therapy is currently ranked 1206 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 1206 in 2024 and its lowest position of 34900 in 2020.
The standard ISO4 abbreviation for the Transplantation and Cellular Therapy is Transplant. Cell. Ther..
Transplantation and Cellular Therapy is classified as a journal that the Elsevier B.V. publishes.
The Transplantation and Cellular Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Transplantation and Cellular Therapy is assigned the following International Standard Serial Numbers (ISSN): 26666367, 26666375.
The best quartile for the Transplantation and Cellular Therapy is Q1 (2024).
The Transplantation and Cellular Therapy coverage history can be summarized as follows: 2021-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 27452 | Walter de Gruyter GmbH | 17 | 0.29 |
| Business: Theory and Practice | journal | 16073 | Vilnius Gediminas Technical University | 31 | 2.45 |
| Journal of Geriatric Physical Therapy | journal | 8686 | Lippincott Williams and Wilkins Ltd. | 53 | 1.55 |
| Criminal Justice Review | journal | 10284 | SAGE Publications Inc. | 46 | 1.91 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Journal of Supply Chain Management | journal | 331 | Wiley-Blackwell | 119 | 9.76 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| British Journal of Special Education | journal | 14055 | Wiley-Blackwell Publishing Ltd | 45 | 1.43 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.05 |
| 2023 | 3.39 |
| 2022 | 3.27 |
| 2021 | 4.27 |
| 2020 | 4.12 |
| 2019 | 3.47 |
| 2018 | 3.34 |
| 2017 | 4.10 |
| 2016 | 4.16 |
| 2015 | 3.65 |
| 2014 | 3.35 |
